(https://www.cnbc.com/2026/06/04/this-medtech-stock-is-trading-at-a-discount-btig-says-its-a-buy-.html) because it's cheap versus peers—classic relative-value trap. But the real story is that *all* medical device makers are facing the same structural headwind: lower/middle-income patients rationing healthcare spend exactly like they're rationing groceries.

Research these companies